Drug information for NEOPROFEN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INTRAVENOUS
EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Prescription
(Reference Drug)
IBUPROFEN LYSINE
solufenum
LUNDBECK LLC
21903
2010-01-04 Label
2009-12-31 Letter
2008-09-16 Letter
2008-04-22 Review
2006-04-14 Label
Drug Adverse Effects information for NEOPROFEN
Role code
Indications
Reaction
# Reports
PS
PRODUCT USED FOR UNKNOWN INDICATION
PRODUCT QUALITY ISSUE
1
Ads by Google